跳至主要内容
临床试验/NCT07109180
NCT07109180招募中不适用

Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA): a Multicenter Randomized Controlled Trial

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2025年4月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
28
试验地点
1
主要终点
Quality of Recovery (QoR-15)

研究概览

简要总结

PANACOTTA is a multicenter randomized controlled trial including patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct to either robot-assisted or open lateral pancreaticojejunostomy. The PANACOTTA trial will assess the post-operative quality of recovery following robot-assisted versus open lateral pancreaticojejunostomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Patient-blinded up to post-operative day 5.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •At least 18 years old
  • •Indication for (extended or partial) lateral pancreaticojejunostomy as agreed during multidisciplinary team meeting based on symptomatic chronic pancreatitis (i.e. morphine dependent pain or recurrent acute flares of pancreatitis, at least 3 episodes per year) and a dilated pancreatic duct of ≥ 5 mm, with a non-enlarged pancreatic head < 40 mm
  • •Confirmed CP, according to the M-ANNHEIM diagnostic Criteria24
  • •Eligible for both an robot-assisted and open approach
  • •Obtained written informed consent

排除标准

  • •Suspected or confirmed current pancreatic cancer
  • •ASA classification ≥ 4
  • •Other painful conditions aside from CP, with pain difficult to discriminate from CP pain
  • •Prior pancreatic surgery
  • •Pregnancy

研究组 & 干预措施

Robot-assisted lateral pancreaticojejunostomy

Experimental

干预措施: Robot-assisted lateral pancreaticojejunostomy (Procedure)

Open lateral pancreaticojejunostomy

Active Comparator

干预措施: Open lateral pancreaticojejunostomy (Procedure)

结局指标

主要结局

Quality of Recovery (QoR-15)

时间窗: Daily assessments on Post-operative Day 1 through Day 5 and up to time of functional recovery, defined individually per patient (maximum of 90 days from surgery).

Primary objective: To assess post-operative mean Quality of Recovery (QoR-15) on post-operative days one through five and cumulative loss of QoR-15 until time of functional recovery of robot-assisted (RA) as compared to open lateral pancreaticojejunostomy (LPJ) in patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct with a normal size pancreatic head.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

M.G. Besselink

M.G. Besselink

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (1)

Loading locations...

相似试验